Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Soybean oil (also known as soya oil) is a natural lipid-based emollient derived from the seeds of the soybean plant (*Glycine max*). In the context of dermatology, it is used as a topical treatment to manage dry skin conditions and atopic dermatitis. It functions as an occlusive emollient, forming a protective film on the skin surface that reduces transepidermal water loss (TEWL) and helps restore the skin's natural barrier function. Soya oil was the primary active ingredient (85%) in Balneum, a bath additive evaluated in the BATHE trial (a Phase 4 pragmatic randomized controlled trial) led by the University of Southampton. The trial investigated the clinical and cost-effectiveness of adding bath emollients to standard care for childhood eczema in UK primary care, ultimately finding no evidence of additional clinical benefit.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on soybean oil.